Skip to content

The Influencing Factors of Vancomycin Trough Level and the Rate Achieving the Target Trough Level

The Influencing Factors of Vancomycin Trough Level and the Rate Achieving the Target Trough Level in Critically Ill Patients: A Retrospective Observational Study

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT03806543
Enrollment
165
Registered
2019-01-16
Start date
2015-01-01
Completion date
2017-12-31
Last updated
2019-01-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Vancomycin

Brief summary

The aim of this study was to assess factors that may influence vancomycin trough level and the rate achieving the target trough level in critically ill patients.

Detailed description

This retrospective observational study included adult patients treated with intravenous vancomycin in intensive care unit of Zhongda Hospital from January 2015 to December 2017. Vancomycin dose was based on international consensus and adjusted according to estimated glomerular filtration rate (eGFR) calculated by the Cockcroft-Gault equation. vancomycin trough level (VTL) was retained at steady state (after the third dose). Linear regression was performed to determine the correlation between factors prior to the first vancomycin dose and VTL. Distribution of VTL and percentage of patients achieving the target trough level (15-20mg/L) was observed in different renal function.

Interventions

DRUGVancomycin

adult patients treated with intravenous vancomycin in intensive care unit

Sponsors

Southeast University, China
Lead SponsorOTHER

Study design

Observational model
CASE_ONLY
Time perspective
RETROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Adult ICU patients (age≥18 years) treated with intravenous vancomycin were included

Exclusion criteria

* Chronic renal dysfunction and acute renal injury patients treated with Renal Replacement therapy * VTL was not retained at steady-state * Vancomycin treatment time≤48h * Vancomycin dose did not meet study definitions * Palliative care

Design outcomes

Primary

MeasureTime frameDescription
Rate of patients achieving the target vancomycin trough(15-20mg/L)3 yearsVancomycin trough level was retained at steady state (after the third dose). If a patient has multiple measurements of vancomycin trough level, the first measurement is collected.Rate of patients achieving the target trough level (15-20mg/L) was observed.

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026